Gilead Sciences Stock Drops After Goldman Says "Sell"

GILD stock has been choppy on the charts in recent months

by Karee Venema

Published on May 28, 2019 at 9:27 AM

Goldman Sachs downgraded Gilead Sciences, Inc. (NASDAQ:GILD) to "sell" from "neutral," and slashed its price target by $10 to $60 -- a discount to last Friday's close at $66.89. The brokerage firm said it sees short-term deceleration in the drugmaker's top-line growth, and said it will likely take time for GILD's new CEO to rebuild the company's pipeline.

In reaction, GILD stock is down 2.4% ahead of the bell. It's been a choppy stretch for the shares since skimming a five-year low near the round $60 mark in late December. While the equity rallied all the way back up to $70 by Feb. 1, it's since been stuck beneath a trendline connecting lower highs, though the $62 level has served as a steady floor in recent months.

Sentiment around Wall Street remains upbeat. While the majority of the 20 analysts in coverage still maintain a "strong buy" rating on GILD shares, a slim 1% of its float is dedicated to short interest.

Meanwhile, in the options pits, the June 65 put is home to peak front-month open interest of almost 10,400 contracts. Data from the major options exchanges confirms significant sell-to-open activity here, meaning put writers expect $65 to serve as a short-term floor for Gilead Sciences stock through June options expiration.

 


a schaeffer's exclusive

PLAY TRENDS LIKE A PRO!

5 tips to leverage profits in this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The IRS Loopholes Retirees Need to Know
Click to continue to advertiser's site.
Karuna Quintuples; Coty Rises on Kylie Deal
Coty bought a sizable stake in Kylie Jenner's business
Call Buyers Stay Behind Huntsman
HUN stock is in focus this morning following bullish brokerage attention
The IRS Loopholes Retirees Need to Know
Click to continue to advertiser's site.